Warhound's Dogs Do Not Exist Yet. The Welfare Questions Do.

A Texas startup conceived by Anduril co-founder Palmer Luckey and Colossal Biosciences co-founder Ben Lamm said on October 22 that it has raised $200 million to gene-edit and clone dogs for military, police and emergency work. ^[2][3]

The company is called Warhound. Its pitch is that dogs can be made healthier and better suited to the job, then fitted with defense-grade equipment from Anduril, the weapons and surveillance technology company Luckey helped found. ^[3]

None of those dogs exist yet. ^[1][2] The promised gains in health, performance and safety are company aims, not demonstrated results.

What the company says it will do

Warhound says it will combine Colossal's genetics, cloning and animal-biology capabilities with Anduril equipment, software and battlefield tools meant to tell a handler where people and threats are around them. The industry calls this situational awareness. ^[3]

Colossal is the biotechnology company known for its work on reviving extinct animals. Warhound's cloning partner will be Viagen, a company Colossal owns, according to TechCrunch. ^[2]

The breeds are Belgian Malinois and German Shepherd lines, the dogs already common in military and police units. ^[2] Lamm told WIRED that the company has collected blood samples from selected high-performing military, police and first-responder dogs, with the aim of cloning them. He said gene-editing work on a first group is under way and the first puppies are expected in early 2027. ^[1]

Lamm told TechCrunch the first dogs could enter service within two years. ^[2]

The first edits, he told WIRED, would target common health problems such as hip dysplasia, a joint disorder in which the hip socket fits badly and wears down. Adding wolf genes for scent detection, specifically genes for the receptors in the nose that pick up odors, is described as a possible later direction and not a finished edit. ^[1]

The gear

The Anduril technology, Lamm told TechCrunch, would be worn and not implanted. His example was a protective vest with data sensors that send information to handlers. ^[2] Warhound's announcement also names eye and ear protection and a system called EagleEye. ^[3] What EagleEye does for a dog, and what the sensors would collect or transmit, has not been spelled out.

David Spirk, Warhound's chief executive, put the goal this way: "healthier dogs, better-prepared teams, and more service members and first responders coming home safely." ^[3] Lamm said in the announcement that the company wants to give working dogs the best possible chance at a long, healthy life and a successful mission. ^[3]

A supply-chain argument

The business case rests on numbers the company supplied and nobody has independently checked. Warhound says more than 80 percent of US military working dogs are sourced from Europe, and that fewer than half of the dogs procured make it through a roughly three-year acquisition and training pipeline. ^[3]

If those figures hold, the Pentagon is buying a scarce animal abroad and then watching more than half of its purchases wash out. Cloning proven dogs is a way to skip the lottery. Warhound is also wagering that editing can improve the odds beyond what breeding gives, though no edited dog has yet shown that it can.

The company says it will build a domestic supply of working dogs for military forces, law enforcement and emergency responders. ^[2][3] It has set no prices.

It expects to sell to government, military-service, police and first-responder customers, and it has briefed government groups about the business. ^[2] No approval, contract or deployment has been reported. ^[2]

Who owns what

Luckey helped conceive Warhound, but WIRED reports that he holds no equity in it and will have no day-to-day role. Anduril, WIRED reports, has no ownership stake. Colossal does own equity. Lamm told WIRED he sits on Warhound's board and that neither he nor Luckey will be involved in day-to-day operations. ^[1]

So the Anduril link is a supply relationship in prospect, not a corporate one. The terms among Warhound, Colossal, Anduril and the investors have not been made public.

The welfare question

Warhound says the American Humane Society will guide its work, certify its training programs and support efforts to reunite retired military dogs with former handlers. ^[2][3] That is a real commitment to something. It is not a commitment to review the genetic edits themselves, and the announcement does not say the Society will do that. ^[3]

That gap is the center of the story. Editing a dog's genes, the instructions in its cells that shape how its body grows and works, to fix hip problems is a different act from editing them to improve a mission trait. Both are different from putting a vest of sensors on an animal sent into a hostile place.

Each raises its own question about standards. Who sets them, from the edit through breeding, service and retirement, and who checks that they are met? Warhound has not said.

There is also a risk question the company has not addressed publicly. How it will assess dangers to handlers and the public when modified dogs work in military or police settings is not known.

What is new here is that the animal itself is the product, designed first and equipped second, by a company whose backers come from both the biotech and the weapons industries. Welfare debates usually trail the technology by years. Here the technology has not even produced a puppy, and the argument has already begun.

The first test is early 2027, when Warhound says the first edited puppies are due. What tests or independent assessments it will publish before offering dogs for service is still an open question. ^[1]